Overview of Dr. Perez
Dr. Lia Perez is a hematologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. She received her medical degree from University of Buenos Aires and has been in practice 26 years. Dr. Perez accepts several types of health insurance, listed below. She is one of 45 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Hematology. She has more than 80 publications and over 500 citings.
Office
12902 Usf Magnolia Dr
Tampa, FL 33612
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1997 - 2000
Brooklyn Hospital CenterResidency, Internal Medicine, 1994 - 1997
University of Buenos AiresClass of 1991
Certifications & Licensure
FL State Medical License 2003 - 2025- American Board of Internal Medicine Hematology
Clinical Trials
- Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation Start of enrollment: 2007 Dec 01
- Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma Start of enrollment: 2009 Jun 18
- Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD) Start of enrollment: 2010 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsBelumosudil Impacts Immunosuppression Pharmacokinetics in Patients with Chronic Graft-versus-Host Disease.Rebecca Gonzalez, Eric Gaskill, Maya Padilla, Joseph Pidala, Aleksandr Lazaryan
Transplantation and Cellular Therapy. 2023-09-01 - 26 citationsA phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantationNelli Bejanyan, Joseph Pidala, Xuefeng Wang, Ram Thapa, Taiga Nishihori
Blood Advances. 2021-03-09 - 23 citationsIn vivo IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation.Joseph Pidala, Francisca Beato, Jongphil Kim, Brian C. Betts, Heather S.L. Jim
Haematologica. 2017-12-14
Abstracts/Posters
- CD34+ Cell Dose Influences Survival after Allogeneic Peripheral Blood Stem Cell Transplantation with Post-Transplant CyclophosphamideLia Perez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Clearance of Somatic Gene Mutations in Patients with Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) Predicts OutcomeLia Perez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Impact of TBI-Based Conditioning Regimen on Outcomes of Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplant: Systematic Revi...Lia Perez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Grant Support
- Clonogenic Characterization Of Myeloma Progenitor CellsNational Cancer Institute2010–2011
- Thrombocytopoiesis In Hematopoietic TransplantationNational Heart, Lung, And Blood Institute2005–2009
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
AvMed Health Open Access
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
CareFirst BluePreferred PPO
CIGNA HMO
CIGNA Open AccessCIGNA PPO
Coventry Florida - Employer Group PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
